Suppression of thymosin β10 increases cell migration and metastasis of cholangiocarcinoma.

Abstract:

BACKGROUND:Thymosin β10 (Tβ10) expression is associated with malignant phenotypes in many cancers. However, the role and mechanisms of Tβ10 in liver fluke-associated cholangiocarcinoma (CCA) are not fully understood. In this study, we investigated the expression of Tβ10 in CCA tumor tissues and cell lines as well as molecular mechanisms of Tβ10 in tumor metastasis of CCA cell lines. METHODS:Tβ10 expression was determined by real time RT-PCR or immunocytochemistry. Tβ10 silence or overexpression in CCA cells was achieved using gene delivery techniques. Cell migration was assessed using modified Boyden chamber and wound healing assay. The effect of silencing Tβ10 on CCA tumor metastasis was determined in nude mice. Phosphorylation of ERK1/2 and the expression of EGR1, Snail and matrix metalloproteinases (MMPs) were studied. RESULTS:Ten pairs of CCA tissues (primary and metastatic tumors) and 5 CCA cell lines were studied. With real time RT-PCR and immunostaining analysis, Tβ10 was highly expressed in primary tumors of CCA; while it was relatively low in the metastatic tumors. Five CCA cell lines showed differential expression levels of Tβ10. Silence of Tβ10 significantly increased cell migration, invasion and wound healing of CCA cells in vitro; reversely, overexpression of Tβ10 reduced cell migration compared with control cells (P<0.05). In addition, silence of Tβ10 in CCA cells increased liver metastasis in a nude mouse model of CCA implantation into the spleen. Furthermore, silence of Tβ10 activated ERK1/2 and increased the expression of Snail and MMPs in CCA cell lines. Ras-GTPase inhibitor, FPT inhibitor III, effectively blocked Tβ10 silence-associated ERK1/2 activation, Snail expression and cell migration. CONCLUSIONS:Low expression of Tβ10 is associated with metastatic phenotype of CCA in vitro and in vivo, which may be mediated by the activation of Ras, ERK1/2 and upregulation of Snail and MMPs. This study suggests a new molecular pathway of CCA pathogenesis and a novel strategy to treat or prevent CCA metastasis.

journal_name

BMC Cancer

journal_title

BMC cancer

authors

Sribenja S,Sawanyawisuth K,Kraiklang R,Wongkham C,Vaeteewoottacharn K,Obchoei S,Yao Q,Wongkham S,Chen C

doi

10.1186/1471-2407-13-430

subject

Has Abstract

pub_date

2013-09-23 00:00:00

pages

430

issn

1471-2407

pii

1471-2407-13-430

journal_volume

13

pub_type

杂志文章
  • MDM2 SNP309 is associated with high grade node positive breast tumours and is in linkage disequilibrium with a novel MDM2 intron 1 polymorphism.

    abstract:INTRODUCTION:A functional polymorphism within MDM2, SNP309 T>G, has been linked to early onset cancer. This study examined clinical associations of breast cancer with SNP309 in a Scottish Caucasian population and investigated additional MDM2 intron 1 polymorphisms. METHODS:Intron 1 of MDM2 was PCR amplified and direct...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/1471-2407-8-281

    authors: Paulin FE,O'Neill M,McGregor G,Cassidy A,Ashfield A,Ali CW,Munro AJ,Baker L,Purdie CA,Lane DP,Thompson AM

    更新日期:2008-10-01 00:00:00

  • Anti-tumor effects of mevalonate pathway inhibition in ovarian cancer.

    abstract:BACKGROUND:Ovarian cancer remains the most fatal gynecological malignancy. Current therapeutic options are limited due to late diagnosis in the majority of the cases, metastatic spread to the peritoneal cavity and the onset of chemo-resistance. Thus, novel therapeutic approaches are required. Statins and amino-bisphosp...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/s12885-020-07164-x

    authors: Göbel A,Zinna VM,Dell'Endice S,Jaschke N,Kuhlmann JD,Wimberger P,Rachner TD

    更新日期:2020-07-29 00:00:00

  • Granulocyte colony-stimulating factors for febrile neutropenia prophylaxis following chemotherapy: systematic review and meta-analysis.

    abstract:BACKGROUND:Febrile neutropenia (FN) occurs following myelosuppressive chemotherapy and is associated with morbidity, mortality, costs, and chemotherapy reductions and delays. Granulocyte colony-stimulating factors (G-CSFs) stimulate neutrophil production and may reduce FN incidence when given prophylactically following...

    journal_title:BMC cancer

    pub_type: 杂志文章,meta分析,评审

    doi:10.1186/1471-2407-11-404

    authors: Cooper KL,Madan J,Whyte S,Stevenson MD,Akehurst RL

    更新日期:2011-09-23 00:00:00

  • CircAGFG1 promotes cervical cancer progression via miR-370-3p/RAF1 signaling.

    abstract:BACKGROUND:In past decades, circular RNAs (circRNAs) have achieved increasing attention because of its regulatory role in different kinds of cancers. However, how circAGFG1 regulates cervical cancer (CC) is still largely undiscovered. This study aims to evaluate the role of a novel circRNAs and related molecular mechan...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/s12885-019-6269-x

    authors: Wu F,Zhou J

    更新日期:2019-11-08 00:00:00

  • An open cohort study of bone metastasis incidence following surgery in breast cancer patients.

    abstract:BACKGROUND:To help design clinical trials of adjuvant bisphosphonate therapy for breast cancer, the temporal incidence of bone metastasis was investigated in a cohort of patients. We have tried to draw the criteria to use adjuvant bisphosphonate. METHODS:Consecutive breast cancer patients undergoing surgery between 19...

    journal_title:BMC cancer

    pub_type: 临床试验,杂志文章

    doi:10.1186/1471-2407-10-381

    authors: Koizumi M,Yoshimoto M,Kasumi F,Iwase T

    更新日期:2010-07-21 00:00:00

  • 14-3-3 zeta is a molecular target in guggulsterone induced apoptosis in head and neck cancer cells.

    abstract:BACKGROUND:The five-year survival rates for head and neck squamous cell carcinoma (HNSCC) patients are less than 50%, and the prognosis has not improved, despite advancements in standard multi-modality therapies. Hence major emphasis is being laid on identification of novel molecular targets and development of multi-ta...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/1471-2407-10-655

    authors: Macha MA,Matta A,Chauhan S,Siu KM,Ralhan R

    更新日期:2010-11-30 00:00:00

  • Pneumatosis cystoides intestinalis associated with sunitinib and a literature review.

    abstract:BACKGROUND:Pneumatosis cystoides intestinalis (PCI) is a rare self-limiting condition characterized by air-filled cysts within intestinal walls. Diagnosis should be prudent because it can mimic pneumoperitoneum leading to unnecessary treatment such as surgical exploration. Although various drugs including anti-neoplast...

    journal_title:BMC cancer

    pub_type: 杂志文章,评审

    doi:10.1186/s12885-017-3744-0

    authors: Lee YS,Han JJ,Kim SY,Maeng CH

    更新日期:2017-11-09 00:00:00

  • Induction of plasminogen activator inhibitor type-1 (PAI-1) by hypoxia and irradiation in human head and neck carcinoma cell lines.

    abstract:BACKGROUND:Squamous cell carcinoma of the head and neck (SCCHN) often contain highly radioresistant hypoxic regions, nonetheless, radiotherapy is a common treatment modality for these tumours. Reoxygenation during fractionated radiotherapy is desired to render these hypoxic tumour regions more radiosensitive. Hypoxia a...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/1471-2407-7-143

    authors: Schilling D,Bayer C,Geurts-Moespot A,Sweep FC,Pruschy M,Mengele K,Sprague LD,Molls M

    更新日期:2007-07-30 00:00:00

  • Early invasive vulvar squamous cell carcinoma arising in a woman with vulvar pemphigus vulgaris and systemic lupus erythematosus.

    abstract:BACKGROUND:Pemphigus vulgaris (PV) is an autoimmune blistering disease of the skin and mucous membranes. Genital involvement occurs when most other common sites are concurrently affected or are in remission. Systemic lupus erythematosus (SLE) is an autoimmune disease that may affect many parts of the body and the skin ...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/1471-2407-10-324

    authors: Bifulco G,Mandato VD,Piccoli R,Giampaolino P,Mignogna C,Mignogna MD,Costagliola L,Nappi C

    更新日期:2010-06-23 00:00:00

  • A cross-sectional study of high-risk human papillomavirus clustering and cervical outcomes in HIV-infected women in Rio de Janeiro, Brazil.

    abstract:BACKGROUND:In Brazil, the rate of cervical cancer remains high despite the availability of screening programs. With ongoing vaccine development and implementation, information on the prevalence of specific HPV types is needed, particularly among high-risk populations, such as HIV-infected women. METHODS:We performed a...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/s12885-015-1486-4

    authors: Castilho JL,Levi JE,Luz PM,Cambou MC,Vanni T,de Andrade A,Derrico M,Veloso VG,Grinsztejn B,Friedman RK

    更新日期:2015-06-23 00:00:00

  • Adjuvant radio-chemotherapy for extrahepatic biliary tract cancers.

    abstract:BACKGROUND:Extrahepatic biliary duct cancers (EBDC) are uncommon malignancies characterized by a poor prognosis with high rate of loco-regional recurrence. The purpose of the present study is to assess the feasibility and the potential impact of adjuvant radiotherapy (RT) in a series of patients treated in one institut...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/1471-2407-11-267

    authors: Bonet Beltrán M,Roth AD,Mentha G,Allal AS

    更新日期:2011-06-24 00:00:00

  • Presentation of breast cancer, help seeking behaviour and experience of patients in their cancer journey in Singapore: a qualitative study.

    abstract:BACKGROUND:Little is known about the presentation, help seeking behaviour for breast cancer in Singapore. Nor was there a study exploring the experience of patients in their breast cancer journey. METHODS:A qualitative interview study with thematic analysis, conducted with 36 patients. RESULTS:There is no clear patte...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/s12885-020-07585-8

    authors: Ng CWQ,Lim JNW,Liu J,Hartman M

    更新日期:2020-11-10 00:00:00

  • Lutetium oxodotreotide (177Lu-Dotatate) for the treatment of unresectable or metastatic progressive gastroenteropancreatic neuroendocrine tumors: a cost-effectiveness analysis for Scotland.

    abstract:BACKGROUND:Gastroenteropancreatic neuroendocrine tumors (GEP-NETs) represent a heterogenous group of tumors. Findings from the phase III NETTER-1 trial showed that treatment of unresectable/metastatic progressive gastrointestinal (GI) NETs with 177Lu-Dotatate resulted in a significant improvement in progression-free su...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/s12885-020-07710-7

    authors: Smith-Palmer J,Leeuwenkamp OR,Virk J,Reed N

    更新日期:2021-01-05 00:00:00

  • Enhanced expression of Vastatin inhibits angiogenesis and prolongs survival in murine orthotopic glioblastoma model.

    abstract:BACKGROUND:Antiangiogenic therapies are considered promising for the treatment of glioblastoma (GB). The non-collagenous C-terminal globular NC1 domain of type VIII collagen a1 chain, Vastatin, is an endogenous antiangiogenic polypeptide. Sustained enhanced expression of Vastatin was shown to inhibit tumour growth and ...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/s12885-017-3125-8

    authors: Li Y,Li J,Woo YM,Shen Z,Yao H,Cai Y,Lin MC,Poon WS

    更新日期:2017-02-13 00:00:00

  • Chemotherapy with cisplatin and vinorelbine for elderly patients with locally advanced or metastatic non-small-cell lung cancer (NSCLC).

    abstract:BACKGROUND:Although modest improvements in the survival of patients with non-small cell lung cancer (NSCLC) can be achieved with cisplatin-based chemotherapy (CT), its value is disputed in the geriatric setting. In this study, we evaluate the feasibility of vinorelbine/cisplatin CT for elderly NSCLC patients. METHODS:...

    journal_title:BMC cancer

    pub_type: 临床试验,杂志文章

    doi:10.1186/1471-2407-4-69

    authors: Pereira JR,Martins SJ,Nikaedo SM,Ikari FK

    更新日期:2004-09-29 00:00:00

  • Suppression of local invasion of ameloblastoma by inhibition of matrix metalloproteinase-2 in vitro.

    abstract:BACKGROUND:Ameloblastomas are odontogenic neoplasms characterized by local invasiveness. This study was conducted to address the role of matrix metalloproteinase-2 (MMP-2) in the invasiveness of ameloblastomas. METHODS:Plasmids containing either MMP-2 siRNA or tissue inhibitor of metalloproteinase-2 (TIMP-2) cDNA were...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/1471-2407-8-182

    authors: Wang A,Zhang B,Huang H,Zhang L,Zeng D,Tao Q,Wang J,Pan C

    更新日期:2008-06-30 00:00:00

  • Reproductive factors and risk of hormone receptor positive and negative breast cancer: a cohort study.

    abstract:BACKGROUND:The association of reproductive factors with hormone receptor (HR)-negative breast tumors remains uncertain. METHODS:Within the EPIC cohort, Cox proportional hazards models were used to describe the relationships of reproductive factors (menarcheal age, time between menarche and first pregnancy, parity, num...

    journal_title:BMC cancer

    pub_type: 杂志文章,多中心研究

    doi:10.1186/1471-2407-13-584

    authors: Ritte R,Tikk K,Lukanova A,Tjønneland A,Olsen A,Overvad K,Dossus L,Fournier A,Clavel-Chapelon F,Grote V,Boeing H,Aleksandrova K,Trichopoulou A,Lagiou P,Trichopoulos D,Palli D,Berrino F,Mattiello A,Tumino R,Sacerdote

    更新日期:2013-12-09 00:00:00

  • Polymorphisms in GSTT1, GSTM1, NAT1 and NAT2 genes and bladder cancer risk in men and women.

    abstract:BACKGROUND:Cigarette smoking is an established risk factor for bladder cancer. Epidemiological and biological data suggest that genetic polymorphisms in activating and detoxifying enzymes may play a role in determining an individual's susceptibility to bladder cancer in particular when in combination with specific envi...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/1471-2407-6-239

    authors: McGrath M,Michaud D,De Vivo I

    更新日期:2006-10-06 00:00:00

  • Use of non-steroidal anti-inflammatory drugs and risk of breast cancer: The Spanish Multi-Case-control (MCC) study.

    abstract:BACKGROUND:The relationship between non-steroidal anti-inflammatory drug (NSAID) consumption and breast cancer has been repeatedly studied, although the results remain controversial. Most case-control studies reported that NSAID consumption protected against breast cancer, while most cohort studies did not find this ef...

    journal_title:BMC cancer

    pub_type: 杂志文章,多中心研究

    doi:10.1186/s12885-016-2692-4

    authors: Dierssen-Sotos T,Gómez-Acebo I,de Pedro M,Pérez-Gómez B,Servitja S,Moreno V,Amiano P,Fernandez-Villa T,Barricarte A,Tardon A,Diaz-Santos M,Peiro-Perez R,Marcos-Gragera R,Lope V,Gracia-Lavedan E,Alonso MH,Michelena-Echeves

    更新日期:2016-08-20 00:00:00

  • The T790M resistance mutation in EGFR is only found in cfDNA from erlotinib-treated NSCLC patients that harbored an activating EGFR mutation before treatment.

    abstract:BACKGROUND:Lung cancer patients with an activating mutation in the EGFR (epidermal growth factor receptor) can develop resistance to erlotinib treatment, which is often mediated by the T790M resistance mutation in EGFR. The difficulties in obtaining biopsies at progression make it challenging to investigate the appeara...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/s12885-018-4108-0

    authors: Demuth C,Madsen AT,Weber B,Wu L,Meldgaard P,Sorensen BS

    更新日期:2018-02-15 00:00:00

  • Inter-observer agreement according to three methods of evaluating mammographic density and parenchymal pattern in a case control study: impact on relative risk of breast cancer.

    abstract:BACKGROUND:Mammographic breast density and parenchymal patterns are well-established risk factors for breast cancer. We aimed to report inter-observer agreement on three different subjective ways of assessing mammographic density and parenchymal pattern, and secondarily to examine what potential impact reproducibility ...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/s12885-015-1256-3

    authors: Winkel RR,von Euler-Chelpin M,Nielsen M,Diao P,Nielsen MB,Uldall WY,Vejborg I

    更新日期:2015-04-12 00:00:00

  • Platinum sensitivity and CD133 expression as risk and prognostic predictors of central nervous system metastases in patients with epithelial ovarian cancer.

    abstract:BACKGROUND:To characterize prognostic and risk factors of central nervous system (CNS) metastases in patients with epithelial ovarian cancer (EOC). METHODS:A retrospective analysis of Xijing Hospital electronic medical records was conducted to identify patients with pathologically confirmed EOC and CNS metastases. In ...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/1471-2407-14-829

    authors: Liu BL,Liu SJ,Baskys A,Cheng H,Han Y,Xie C,Song H,Li J,Xin XY

    更新日期:2014-11-17 00:00:00

  • A systematic review reporting quality of radiomics research in neuro-oncology: toward clinical utility and quality improvement using high-dimensional imaging features.

    abstract:BACKGROUND:To evaluate radiomics analysis in neuro-oncologic studies according to a radiomics quality score (RQS) system to find room for improvement in clinical use. METHODS:Pubmed and Embase were searched up the terms radiomics or radiogenomics and gliomas or glioblastomas until February 2019. From 189 articles, 51 ...

    journal_title:BMC cancer

    pub_type: 杂志文章,meta分析

    doi:10.1186/s12885-019-6504-5

    authors: Park JE,Kim HS,Kim D,Park SY,Kim JY,Cho SJ,Kim JH

    更新日期:2020-01-10 00:00:00

  • The NeST (Neoadjuvant systemic therapy in breast cancer) study: National Practice Questionnaire of United Kingdom multi-disciplinary decision making.

    abstract:BACKGROUND:Neoadjuvant systemic therapy (NST) is increasingly used in the treatment of breast cancer, yet it is clear that there is significant geographical variation in its use in the UK. This study aimed to examine stated practice across UK breast units, in terms of indications for use, radiological monitoring, patho...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/s12885-020-07757-6

    authors: Whitehead I,Irwin GW,Bannon F,Coles CE,Copson E,Cutress RI,Dave RV,Gardiner MD,Grayson M,Holcombe C,Irshad S,O'Brien C,O'Connell RL,Palmieri C,Shaaban AM,Sharma N,Singh JK,Potter S,McIntosh SA,NeST Study Research Co

    更新日期:2021-01-22 00:00:00

  • Identification of a metastatic lung adenocarcinoma of the palate mucosa through genetic and histopathological analysis: a rare case report and literature review.

    abstract:BACKGROUND:Cancers of unknown primary origin (CUPs) are reported to be the 3-4th most common causes of cancer death. Recent years have seen advances in mutational analysis and genomics profiling. These advances could improve accuracy of diagnosis of CUPs and might improve the prognosis of patients with CUPs. CASE PRES...

    journal_title:BMC cancer

    pub_type: 杂志文章,评审

    doi:10.1186/s12885-019-5277-1

    authors: Abe M,Watanabe K,Shinozaki-Ushiku A,Ushiku T,Abe T,Fujihara Y,Amano Y,Zong L,Wang CP,Kubo E,Inaki R,Kinoshita N,Yamashita S,Takai D,Ushijima T,Nagase T,Hoshi K

    更新日期:2019-01-11 00:00:00

  • Identification of S100A8-correlated genes for prediction of disease progression in non-muscle invasive bladder cancer.

    abstract:BACKGROUND:S100 calcium binding protein A8 (S100A8) has been implicated as a prognostic indicator in several types of cancer. However, previous studies are limited in their ability to predict the clinical behavior of the cancer. Here, we sought to identify a molecular signature based on S100A8 expression and to assess ...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/1471-2407-10-21

    authors: Kim SK,Kim EJ,Leem SH,Ha YS,Kim YJ,Kim WJ

    更新日期:2010-01-25 00:00:00

  • Amplification of HER2 is a marker for global genomic instability.

    abstract:BACKGROUND:Genomic alterations of the proto-oncogene c-erbB-2 (HER-2/neu) are associated with aggressive behavior and poor prognosis in patients with breast cancer. The variable clinical outcomes seen in patients with similar HER2 status, given similar treatments, suggests that the effects of amplification of HER2 can ...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/1471-2407-8-297

    authors: Ellsworth RE,Ellsworth DL,Patney HL,Deyarmin B,Love B,Hooke JA,Shriver CD

    更新日期:2008-10-14 00:00:00

  • Low prevalence of p16-positive HPV-related head-neck cancers in Thailand: tertiary referral center experience.

    abstract:BACKGROUND:There has been a sharp rise in the incidence of human papillomavirus (HPV) associated oropharyngeal squamous cell carcinoma (OPSCC) in many countries. Patients with HPV-positive OPSCC have a more favorable prognosis compared with HPV-negative OPSCC, leading to investigation and adoption of de-escalation trea...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/s12885-019-6266-0

    authors: Nopmaneepaisarn T,Tangjaturonrasme N,Rawangban W,Vinayanuwattikun C,Keelawat S,Bychkov A

    更新日期:2019-11-06 00:00:00

  • DEK is a potential marker for aggressive phenotype and irinotecan-based therapy response in metastatic colorectal cancer.

    abstract:BACKGROUND:DEK is a transcription factor involved in stabilization of heterochromatin and cruciform structures. It plays an important role in development and progression of different types of cancer. This study aims to analyze the role of DEK in metastatic colorectal cancer. METHODS:Baseline DEK expression was firstly...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/1471-2407-14-965

    authors: Martinez-Useros J,Rodriguez-Remirez M,Borrero-Palacios A,Moreno I,Cebrian A,Gomez del Pulgar T,del Puerto-Nevado L,Vega-Bravo R,Puime-Otin A,Perez N,Zazo S,Senin C,Fernandez-Aceñero MJ,Soengas MS,Rojo F,Garcia-Foncillas J

    更新日期:2014-12-16 00:00:00

  • Enhanced antitumor efficacy of cisplatin in combination with HemoHIM in tumor-bearing mice.

    abstract:BACKGROUND:Although cisplatin is one of the most effective chemotherapeutic agents, cisplatin alone does not achieve a satisfactory therapeutic outcome. Also cisplatin accumulation shows toxicity to normal tissues. In this study, we examined the possibility of HemoHIM both to enhance anticancer effect with cisplatin an...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/1471-2407-9-85

    authors: Park HR,Ju EJ,Jo SK,Jung U,Kim SH,Yee ST

    更新日期:2009-03-17 00:00:00